col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


34 Ergebisse       Seite 1

 [1] 
Wiley: Journal of Clinical Pharmacy and Therapeutics
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Aug―12 A Systematic Assessment of Drug Repurposing Efforts Against COVID-19: Limited Successes and Key Challenges Andreas Riedel, Peter Ruth, Markus W. Löffler, Nicolai Stransky, Muhammad Iqhrammullah
2 [GO] 2024―Jul―25 Association between Pandemic of COVID-19 and Influenza Vaccine Take-Up in 2020-2021 in Maine et Loire (France) Juliette Abline, Anicet Chaslerie, Emmanüele Fabre, Alain Heymans, Pascal Artarit, Sébastien Faure, et al. (+2)
3 [GO] 2023―Okt―09 In Silico Screening, In Vitro Mpro Inhibitory, and Adjunctive Therapy Value of Minocycline for the Treatment of COVID-19 Yaru Han, Xianxiang Bai, Si Wu, Xiurong Luan, Liwen Ren, Jinhua Wang, et al. (+4)
4 [GO] 2022―Aug―22 Antibiotic use during the first 6 months of COVID -19 pandemic in Iran: A large-scale multi-centre study Mohammadreza Salehi, Hossein Khalili, Arash Seifi, Hamidreza Davoudi, Ilad Alavi Darazam, Zahra Jahangard-Rafsanjani, et al. (+22)
5 [GO] 2022―Jun―14 Critical care tele-pharmacy services during COVID -19 pandemic: A qualitative exploration of healthcare practitioners' perceptions Nour Isleem, Sadim Shoshaa, Ahmad AbuGhalyoun, Mohamad Khatib, Lina Mohammad Naseralallah, Mohammed Ibn-Mas'ud Danjuma, Mohamed Saad
6 [GO] 2022―Mai―28 SARS-CoV -2 neutralizing antibodies for COVID-19: Outcomes for bamlanivimab versus bamlanivimab-etesevimab combination in a racially diverse cohort of patients with significant comorbidities Lea M. Monday, Indira Brar, George Alangaden, Mayur S. Ramesh
7 [GO] 2022―Mrz―21 Incidence and risk factors for hyperkalaemia in patients treated for COVID-19 with nafamostat mesylate Kentaro Kodama, Toru Imai, Yasuo Asai, Yutaka Kozu, Kentaro Hayashi, Tetsuo Shimizu, et al. (+2)
8 [GO] 2022―Feb―07 Omicron variant as nature's solution to the COVID-19 pandemic Alain Li Wan Po
9 [GO] 2021―Dez―24 Does COVID-19 increase tacrolimus levels in kidney transplant recipients? Divya Bajpai, Nikhil Saxena, Chintan Gandhi, Tulsi Modi, Sreyashi Bose, Satarupa Deb, et al. (+11)
10 [GO] 2021―Nov―12 Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia Archana Roy, Harry Ross Powers, Emily C. Craver, Mark D. Nazareno, Siva Naga S. Yarrarapu, Devang K. Sanghavi
11 [GO] 2021―Sep―04 Evaluation of a web-based educational programme for pharmacists during the COVID-19 pandemic in Japan Masami Tsuchiya, Hideyuki Terazono, Yosuke Maki, Naoki Yoshikawa, Yosuke Kawahara, Keiko Nishimura, et al. (+8)
12 [GO] 2021―Aug―25 Suboptimal plasma concentrations with posaconazole suspension as prophylaxis in critically ill COVID-19 patients at risk of Covid-associated pulmonary aspergillosis Paola Mian, Ronald J. Trof, Albertus Beishuizen, Joost B. Masselink, Alexander D. Cornet, Esther T. Sportel
13 [GO] 2021―Aug―02 Elevated INR in a COVID-19 patient after concomitant administration of favipiravir and warfarin: A case report Masao Sekimoto, Toru Imai, Shinji Hidaka, Nobutaka Chiba, Atsushi Sakurai, Mitsumasa Hata, Norikazu Kikuchi
14 [GO] 2021―Jul―13 Participation in ENSEMBLE phase III multicenter clinical trial of Ad26.CoV2.S, a COVID-19 vaccine: An investigational drug services perspective Nan Li
15 [GO] 2021―Mai―28 Improving COVID-19 vaccine-related health literacy and vaccine uptake in patients: Comparison on the readability of patient information leaflets of approved COVID-19 vaccines John E. Moore, Beverley C. Millar
16 [GO] 2021―Mai―08 Medication safety in a pandemic: A multicentre point prevalence study of QTc monitoring of hydroxychloroquine for COVID-19 Steven M. Smoke, Henry Leach, Nicole Leonida, Karan Raja, Monica Shah, Vishal Patel, et al. (+4)
17 [GO] 2021―Mrz―26 QT prolongation associated with hydroxychloroquine and protease inhibitors in COVID-19 Hui Moon Koh, Pei Feng Chong, Ju Nee Tan, Suresh Kumar Chidambaram, Hiu Jian Chua
18 [GO] 2021―Mrz―26 The outcomes and acceptance of pressurized metered-dose inhaler bronchodilators with venturi mask modified spacer in the outpatient emergency department during the COVID-19 pandemic Hock Peng Koh, Nurul Shaliza Shamsudin, Marilyn May Yeen Tan, Zulsairi Mohd Pauzi
19 [GO] 2021―Mrz―18 Safe handling and delivery of biological medications during the COVID-19 pandemic Amnah Mukhtar, Murooj Shukry, Douha Bannan
20 [GO] 2021―Mrz―01 Repurposing functional inhibitors of acid sphingomyelinase (fiasmas): an opportunity against SARS-CoV-2 infection? Pascal Le Corre, Gwenolé Loas
21 [GO] 2021―Feb―27 Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study Inés Jiménez-Lozano, José Manuel Caro-Teller, Nuria Fernández-Hidalgo, Marta Miarons, Marie Antoinette Frick, Emma Batllori Badia, et al. (+8)
22 [GO] 2020―Dez―25 Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments Noemí Martínez-López-de-Castro, Marisol Samartín-Ucha, Adolfo Paradela-Carreiro, Antonio Pérez-Landeiro, María Teresa Inaraja-Bobo, Miriam Álvarez-Payero, et al. (+14)
23 [GO] 2020―Nov―21 Breakthrough venous thromboembolic events in five patients with COVID-19 on direct oral anticoagulants Paul Lewis, Jennifer L. Tharp
24 [GO] 2020―Nov―21 The Zika virus: Lurking behind the COVID-19 pandemic? Joseph Pergolizzi, Jo Ann LeQuang, Sumiyo Umeda-Raffa, Charles Fleischer, Joseph Pergolizzi, Claudio Pergolizzi, Robert B. Raffa
25 [GO] 2020―Okt―31 Observational study of the effects of Favipiravir vs Lopinavir/Ritonavir on clinical outcomes in critically Ill patients with COVID-19 Havva Kocayiğit, Kezban Özmen Süner, Yakup Tomak, Gürkan Demir, Selçuk Yaylacı, Hamad Dheir, et al. (+2)
26 [GO] 2020―Okt―26 Bone fractures during the time of coronavirus Sumiyo Umeda-Raffa, Joseph V. Pergolizzi Jr, Robert B. Raffa
27 [GO] 2020―Okt―24 Tocilizumab use in patients with moderate to severe COVID-19: A retrospective cohort study Sridhar Chilimuri, Haozhe Sun, Ahmed Alemam, Kyoung-Sil Kang, Peter Lao, Nikhitha Mantri, et al. (+6)
28 [GO] 2020―Okt―21 Role of clinical pharmacists in telemonitoring for patients with Coronavirus Disease 2019 (COVID-19) Bhitta Surapat, Somnuek Sungkanuparph, Suppachok Kirdlarp, Nantaporn Lekpittaya, Krittaya Chunnguleum
29 [GO] 2020―Sep―27 Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing Rashmi R. Shah
30 [GO] 2020―Aug―29 Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19 Adeleh Sahebnasagh, Fatemeh Saghafi, Mohammadreza Safdari, Masoud Khataminia, Afsaneh Sadremomtaz, Zeinab Talaei, et al. (+4)
31 [GO] 2020―Aug―08 Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis Jessica Barochiner, Rocío Martínez
32 [GO] 2020―Jul―31 Characteristics of Clinical Trials relating to COVID-19 registered at ClinicalTrials.gov Yuhui Wang, Qi Zhou, Mengqi Xu, Jian Kang, Yaolong Chen
33 [GO] 2020―Jul―21 QTc prolongation during antiviral therapy in two COVID-19 patients Suyan Zhu, Jian Wang, Yong Wang, Jinguo Chu, Yao Liu, Xueqin Chen, Xiaomin Chen
34 [GO] 2020―Mai―25 Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019 Qiuxiang Yang, Ling Xie, Wei Zhang, Lin Zhao, HuaJun Wu, Jie Jiang, et al. (+5)
 [1] 

34 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.007 sec